维普中文期刊产品整合服务
12篇 您的检索式:作者名="Borum L"
    题名 作者 年代 出处 被引量
1Surface modification of hydroxyapatite 显示文摘Borum L Wilson J O C 2003PartII Silica Biomaterials2003,24,:1
2Peptic-ulcer disease in the elderly显示文摘BORUM M L 1999Clin Geriatr Med1999,15,:1
3Irritable bowel syndrome显示文摘Borum M L 2001Prim Care2001,28,3:1
4Surface modification of hydroxyapatite:part Ⅱ:silica显示文摘BORUM L WILSON O C 0,,:1
5Surface modification of hydroxyapatite 显示文摘Borum L 2003Biomaterials2003,24,:1
6Inheritance and localisation of resistance to Mycosphaerella graminicola causing septoria tritici blotch and plant height in the wheat(Triticum aestivum L) genome with DNA markers显示文摘Eriksen L Borum F Jahoor A 0,,03:1
7Direct flows of phosphorus and suspended matter from a fish farm to wild fish in Lake Southern Bullaren, Sweden显示文摘Johansson T Hakanson L Borum K 1998Aquacultural Engineering1998,17,2:1
8Replantaion of 400 avulsed permanent incisors 4 factors related to periodontal ligament healing显示文摘Andreasen J O Borum M K Jacobsen H L 0,,02:1
9Depth colonization of eelgrass (Zostera marina) and macroalgae as determined by water transparency in Danish coastal waters 显示文摘Nielsen S L Sand-Jensen K Borum J 2002Estuaries Coasts2002,25,:1
10Aspects of nitrogen acquisition and conservation in eelgrass plants显示文摘Borum j Murray L Kemp W M 1989A- quatic Botany1989,35,34:1
11Could there be light at the end of the tunnel? Mesocaval shunting for refractory esophageal varices in patients with contraindications to transjugular intrahepatic portosystemic shunt显示文摘Cirrhotic patients with recurrent variceal bleeds who have failed prior medical and endoscopic therapies and are not transjugular intrahepatic portosystemic shunt candidates face a grim prognosis with limited options. We propose that mesocaval shunting be offered to this group of patients as it has the potential to decrease portal pressures and thus decrease the risk of recurrent variceal bleeding. Mesocaval shunts are stent grafts placed by interventional radiologists between the mesenteric system, most often the superior mesenteric vein, and the inferior vena cava. This allows flow to bypass the congested hepatic system, reducing portal pressures. This technique avoids the general anesthesia and morbidity associated with surgical shunt placement and has been successful in several case reports. In this paper we review the technique, candidate selection, potential pitfalls and benefits of mesocaval shunt placement.Jessica Davis Albert K Chun Marie L Borum 2016World Journal of Hepatology2016,8,19:0
12Pregnant inflammatory bowel disease patients may require counselling regarding live vaccines in newborns显示文摘Inflammatory bowel disease patients are prone to immunosuppression due to effects of their medications. Physicians are recommended to assess vaccination status and overall health in all patients, prior to initiation of immunosuppressive therapy. Immunosuppressant medications in women with inflammatory bowel disease are often continued during pregnancy, which can result in newborns having an increased risk of immunosuppression at birth. While medication-induced immunosuppression in infants is transient, parents should be counselled about delaying live vaccine administration in newborns until they are immune competent. A retrospective study was done over six months at an urban multispecialty medical center to assess whether physicians are counselling pregnant immunosuppressed inflammatory bowel disease patients regarding live vaccinations in their newborns. The study revealed that only 57% of patients had documented counselling in their charts. Further studies are necessary to determine physician counselling practices of pregnant women about live vaccines. It is critical that physicians and patients are aware of the risks of immunosuppression in pregnancy and the potential impact of live vaccinesupon the newborn.Adith Sekaran Marie L Borum 2014World Journal of Gastroenterology2014,20,33:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费